What are their applications in treatment of chronic hepatitis B?
2
据估计，20 - 30%的乙肝病毒感染者能够从治疗中获益。
It is estimated that 20-30% of persons with HBV infection could benefit from treatment.
3
1998年首个核苷类似物药物拉米夫定推出之前，慢性乙肝病毒感染者可选的有效治疗途径一直都非常有限。
Effective treatment options for individuals with chronic hepatitis B infection were limited until 1998 when lamivudine, the first nucleoside analogue drug, was introduced.
点击反馈